|
发布时间：2011-03-25 - 点击：3次 - 字数：1961字 | Gentel Biosciences, a leader in proteomics tools, and Van Andel Research Institute (VARI), a biomedical research institute, jointly announce today the granting of U.S. Patent 7,838,634 for a new method to profile changes in the... |
|
发布时间：2011-03-24 - 点击：2次 - 字数：1106字 | Colorcon, Inc., a wholly owned subsidiary of BPSI Holdings Inc., today announced specific details on its world-wide patent positions for enteric coating compositions in response to misleading statements made in the international press,... |
|
发布时间：2011-03-24 - 点击：3次 - 字数：2410字 | Advanced Cell Technology, Inc. ( ACT ; OTC Bulletin Board: ACTC), a leader in the field of regenerative medicine, announced today that China's State Intellectual Property Office (SIPO) has allowed the Company's patent application... |
|
发布时间：2011-03-24 - 点击：2次 - 字数：1398字 | NephRx Corporation today announced issuance of a new U.S. patent for use of its novel growth factor peptide NX002 as a potential treatment for inflammatory bowel disease (IBD). Animal studies suggest that NX002 may have applications in... |
|
发布时间：2011-03-24 - 点击：2次 - 字数：1244字 | ULURU Inc. (NYSE AMEX: ULU) announced today that it has been issued U.S. Patent 7,910,135 Hydrogel Wound Dressing and Biomaterials Formed In Situ and Their Uses. This patent provides additional coverage for Altrazeal and... |
|
发布时间：2011-03-23 - 点击：4次 - 字数：1879字 | NephRx Corporation today announced issuance of a new U.S. patent for its novel peptide NX002, which currently is in preclinical development for the treatment of oral mucositis. Previously, NephRx reported that NX002 had... |
|
发布时间：2011-03-23 - 点击：2次 - 字数：1473字 | Pro-Pharmaceuticals, Inc. (OTC: PRWP), the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that the Company has been granted two new patents, Co-administration of a... |
|
发布时间：2011-03-23 - 点击：5次 - 字数：1598字 | POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to transforming medicines that transform lives, today announced that it has filed a motion for a preliminary injunction seeking to prevent Par Pharmaceuticals, Inc. (Par) from... |
|
发布时间：2011-03-22 - 点击：2次 - 字数：975字 | BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced the issuance of a patent extending the exclusivity of the BioErodible MucoAdhesive (BEMA) drug delivery technology in Canada from 2017 to 2027. The patent was been... |
|
发布时间：2011-03-22 - 点击：2次 - 字数：2621字 | HistoRx, Inc., announced today that the U.S. Patent and Trademark Office has granted a patent protecting the company's methods for standardization of digital microscopy instruments in order to go beyond imaging to generating high-quality... |
|
发布时间：2011-03-17 - 点击：3次 - 字数：1681字 | GenSpera, Inc. (OTC.BB: GNSZ) announced that its patent application, entitled Activation of Peptide Prodrugs by HK2, has been issued by the United States Patent and Trademark Office (USPTO) as US Patent 7,906,477. The patent covers the... |
|
发布时间：2011-03-17 - 点击：3次 - 字数：894字 | A lawsuit was filed against Biotage by Scientific Plastic Products, Inc. concerning alleged infringement of the US patents no 7,138,061, 7,381,327 and 7,410,571. Biotage then filed an application to the US Patent and Trademark Office... |
|
发布时间：2011-03-16 - 点击：2次 - 字数：1226字 | Hamamatsu Photonics K.K. (HPK) is pleased to announce that is has been awarded Reissue Patent No. 42,220 ( RE42,220 ), confirming the patentability of its original Patent 6,847,729, a pioneering patent directed to slide scanning with... |
|
发布时间：2011-03-16 - 点击：2次 - 字数：1395字 | Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced the signing of a global settlement agreement among Alnylam, Max Planck Society ( Max Planck ), the Whitehead Institute for... |
|
发布时间：2011-03-15 - 点击：9次 - 字数：1578字 | Argentum Medical, LLC today issued a response to the recent decision in their patent infringement litigation versus Noble Biomaterials, Inc. The most important thing to know is the trial has no impact on our patents and it is business as... |
|
|